How serious is FDA warning about revolutionary blood-cancer

Dana-Farber Cancer Institute researcher details promise, peril of CAR T-cell therapy, which enlists body’s immune system to fight disease.

FDA Issues Stark Warning Against Unapproved Smartwatches and Rings for Blood Glucose Monitoring

James Wang, PhD on LinkedIn: Porton Advanced and Ascle Therapeutics Reached a Strategic Partnership to…

Mark Flower on LinkedIn: Updated: FDA approves Sarepta's Duchenne muscular dystrophy gene therapy…

At $475,000, is Novartis' Kymriah a bargain—or another example of skyrocketing prices?

FDA issues urgent warning as cancer treatment may actually increase cancer risk - Health - News - Daily Express US

Skipping Adjuvant Radiotherapy May Not Impact Risk of Recurrence or Progression in Patients with Low-Risk DCIS - Be part of the knowledge - ReachMD

Archives — Page 5 of 875 — Harvard Gazette

James Wang, PhD on LinkedIn: Bispecific CAR T-Cell Therapy Has “Robust” Activity in Non-Hodgkin Lymphoma

FDA puts Gilead's blood cancer drug studies on hold

FDA announces first US gene therapy approval for cancer treatment

Eric Smith (@ESmithMDPhD) / X

Mark Flower on LinkedIn: Julie Kanter, MD, on Preparing for Anticipated Approval of Lovo-Cel for…

ICancer Event

Eric Smith (@ESmithMDPhD) / X